GeneCapture Validates Lab-Free ‘Sample to Prescription’ Infectious Disease Protocol in 2 Hours Instead of 3 Days

GeneCapture Validates Lab-Free Infection Diagnosis in 2 Hours

March 25, 2026

When a patient comes in with a suspected bacterial infection, the standard of care today means sending a sample to a laboratory and waiting two to three days for results. In the meantime, doctors make their best guess on treatment, patients stay sick, and the risk of complications like sepsis grows.

GeneCapture is closing that gap.

This week, the Huntsville-based company demonstrated its portable, lab-free diagnostic platform to local clinicians and physicians, validating a workflow that moves from raw sample to prescription guidance in just 2 hours, with a 98% match to gold-standard hospital results. The platform requires no laboratory, running instead on a small disposable cartridge and a compact instrument that delivers results to a mobile device.

The technology identifies the right antibiotic by testing it directly against the patient's own pathogen, combining sequence-based probes, biochemical reactions, and optical cytometry in a process that can detect up to 200 pathogens. The current study focused on urinary tract infections, a condition that can escalate rapidly without prompt and accurate treatment.

GeneCapture has completed the FDA pre-submission process and is now preparing for clinical trials. Read the full press release here.